Insider Buy/Sell Details for the Healthcare Sector — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2172)
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
18,405
Price
$215.62
Total Value
$3.97M
Shares Held After
1,760,638
% of Holdings
1.0%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
42,218
Price
$214.57
Total Value
$9.06M
Shares Held After
1,779,043
% of Holdings
2.3%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
71,939
Price
$213.36
Total Value
$15.35M
Shares Held After
1,821,261
% of Holdings
3.8%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
29,805
Price
$212.83
Total Value
$6.34M
Shares Held After
1,893,200
% of Holdings
1.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
34,009
Price
$211.90
Total Value
$7.21M
Shares Held After
1,923,005
% of Holdings
1.7%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
23,638
Price
$210.66
Total Value
$4.98M
Shares Held After
1,957,014
% of Holdings
1.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
9,078
Price
$209.68
Total Value
$1.90M
Shares Held After
1,980,652
% of Holdings
0.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
3,563
Price
$208.55
Total Value
$743.06K
Shares Held After
1,989,730
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
1,132
Price
$207.65
Total Value
$235.06K
Shares Held After
1,993,293
% of Holdings
0.1%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
77
Price
$396.37
Total Value
$30.52K
Shares Held After
958
% of Holdings
7.4%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
66,711
Price
$1.51
Total Value
$101.00K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
67,741
Price
$1.51
Total Value
$102.59K
Shares Held After
48,750
% of Holdings
58.2%
GILEAD SCIENCES, INC. (GILD)
Bluestone Jeffrey — Director
Shares
335
Price
$146.26
Total Value
$49.00K
Shares Held After
10,066
% of Holdings
3.2%
GILEAD SCIENCES, INC. (GILD)
Bluestone Jeffrey — Director
Shares
26
Price
$146.36
Total Value
$3.81K
Shares Held After
10,066
% of Holdings
0.3%
GILEAD SCIENCES, INC. (GILD)
Bluestone Jeffrey — Director
Shares
1,658
Price
$145.73
Total Value
$241.62K
Shares Held After
10,066
% of Holdings
14.1%
GILEAD SCIENCES, INC. (GILD)
Bluestone Jeffrey — Director
Shares
1,816
Price
$144.92
Total Value
$263.18K
Shares Held After
10,066
% of Holdings
15.3%
GILEAD SCIENCES, INC. (GILD)
Bluestone Jeffrey — Director
Shares
1,165
Price
$143.75
Total Value
$167.47K
Shares Held After
10,066
% of Holdings
10.4%
Hinge Health, Inc. (HNGE)
Leslie Kristina M — Director
Shares
1,200
Price
$88.23
Total Value
$105.88K
Shares Held After
30,387
% of Holdings
3.8%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
4,852
Price
$6.27
Total Value
$30.41K
Shares Held After
3,185,246
% of Holdings
0.2%
MYOMO, INC. (MYO)
Kovelman Harry — Chief Medical Officer
Shares
17,250
Price
$1.73
Total Value
$29.90K
Shares Held After
105,983
% of Holdings
14.0%
OMEROS CORP (OMER)
Cable Thomas J. — Director
Shares
15,000
Price
$18.45
Total Value
$276.77K
Shares Held After
35,067
% of Holdings
30.0%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
51,884
Price
$19.46
Total Value
$1.01M
Shares Held After
321,386
% of Holdings
13.9%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
691
Price
$72.92
Total Value
$50.39K
Shares Held After
1,361,594
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
2,390
Price
$71.88
Total Value
$171.79K
Shares Held After
1,362,285
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,419
Price
$70.78
Total Value
$666.68K
Shares Held After
1,364,675
% of Holdings
0.7%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
4,592
Price
$8.41
Total Value
$38.61K
Shares Held After
572,295
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
193
Price
$526.97
Total Value
$101.71K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$525.10
Total Value
$126.02K
Shares Held After
324,636
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$523.26
Total Value
$418.61K
Shares Held After
324,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
960
Price
$522.37
Total Value
$501.48K
Shares Held After
325,676
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,470
Price
$521.39
Total Value
$1.29M
Shares Held After
326,636
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,357
Price
$520.46
Total Value
$1.23M
Shares Held After
329,106
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,504
Price
$519.51
Total Value
$781.34K
Shares Held After
331,463
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
976
Price
$518.45
Total Value
$506.01K
Shares Held After
332,967
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
120
Price
$527.21
Total Value
$63.27K
Shares Held After
45,172
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
400
Price
$526.38
Total Value
$210.55K
Shares Held After
45,292
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
940
Price
$525.25
Total Value
$493.74K
Shares Held After
45,692
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
192
Price
$523.69
Total Value
$100.55K
Shares Held After
46,632
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
850
Price
$522.78
Total Value
$444.37K
Shares Held After
46,824
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
787
Price
$522.00
Total Value
$410.82K
Shares Held After
47,674
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,819
Price
$521.04
Total Value
$947.77K
Shares Held After
48,461
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
502
Price
$520.03
Total Value
$261.06K
Shares Held After
50,280
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,690
Price
$524.15
Total Value
$1.41M
Shares Held After
50,782
% of Holdings
5.0%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
114,700
Price
$4.54
Total Value
$520.74K
Shares Held After
2,465,298
% of Holdings
4.4%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
27,174
Price
$618.79
Total Value
$16.81M
Shares Held After
561,195
% of Holdings
4.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
3,056
Price
$44.16
Total Value
$134.95K
Shares Held After
219,301
% of Holdings
1.4%
REPLIGEN CORP (RGEN)
Loeillot Olivier — Director
Shares
5,426
Price
$180.00
Total Value
$976.68K
Shares Held After
54,246
% of Holdings
9.1%
Liquidia Corp (LQDA)
Rielly-Gauvin Katherine — Director
Shares
18,393
Price
$72.23
Total Value
$1.33M
Shares Held After
44,637
% of Holdings
29.2%
Elanco Animal Health Inc (ELAN)
Kurzius Lawrence Erik — Director
Shares
40,000
Price
$23.40
Total Value
$935.92K
Shares Held After
188,647
% of Holdings
21.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$8.79
Total Value
$439.43K
Shares Held After
800,000
% of Holdings
6.2%
Showing 101–150 of 2172 transactions (page 3 of 44)